Global Vaccine Technologies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Technologies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Infection
1.2.3 Allergy
1.2.4 Cancer
1.3 Market by Application
1.3.1 Global Vaccine Technologies Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Humans
1.3.3 Animals
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vaccine Technologies Market Size (2017-2028)
2.2 Vaccine Technologies Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Vaccine Technologies Market Size by Region (2017-2022)
2.4 Global Vaccine Technologies Market Size Forecast by Region (2023-2028)
2.5 Global Top Vaccine Technologies Countries Ranking by Market Size
3 Vaccine Technologies Competitive by Company
3.1 Global Vaccine Technologies Revenue by Players
3.1.1 Global Vaccine Technologies Revenue by Players (2017-2022)
3.1.2 Global Vaccine Technologies Market Share by Players (2017-2022)
3.2 Global Vaccine Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Vaccine Technologies Revenue
3.4 Global Vaccine Technologies Market Concentration Ratio
3.4.1 Global Vaccine Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Technologies Revenue in 2021
3.5 Global Vaccine Technologies Key Players Head office and Area Served
3.6 Key Players Vaccine Technologies Product Solution and Service
3.7 Date of Enter into Vaccine Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vaccine Technologies Breakdown Data by Type
4.1 Global Vaccine Technologies Historic Revenue by Type (2017-2022)
4.2 Global Vaccine Technologies Forecasted Revenue by Type (2023-2028)
5 Global Vaccine Technologies Breakdown Data by Application
5.1 Global Vaccine Technologies Historic Market Size by Application (2017-2022)
5.2 Global Vaccine Technologies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vaccine Technologies Revenue by Company (2020-2022)
6.2 North America Vaccine Technologies Revenue by Type (2017-2028)
6.3 North America Vaccine Technologies Revenue by Application (2017-2028)
6.4 North America Vaccine Technologies Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Vaccine Technologies Revenue by Company (2020-2022)
7.2 Europe Vaccine Technologies Revenue by Type (2017-2028)
7.3 Europe Vaccine Technologies Revenue by Application (2017-2028)
7.4 Europe Vaccine Technologies Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccine Technologies Revenue by Company (2020-2022)
8.2 Asia Pacific Vaccine Technologies Revenue by Type (2017-2028)
8.3 Asia Pacific Vaccine Technologies Revenue by Application (2017-2028)
8.4 Asia Pacific Vaccine Technologies Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Vaccine Technologies Revenue by Company (2020-2022)
9.2 Latin America Vaccine Technologies Revenue by Type (2017-2028)
9.3 Latin America Vaccine Technologies Revenue by Application (2017-2028)
9.4 Latin America Vaccine Technologies Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Technologies Revenue by Company (2020-2022)
10.2 Middle East and Africa Vaccine Technologies Revenue by Type (2017-2028)
10.3 Middle East and Africa Vaccine Technologies Revenue by Application (2017-2028)
10.4 Middle East and Africa Vaccine Technologies Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccine Technologies Products and Services
11.1.4 Abbott Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.1.5 Abbott Vaccine Technologies SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Vaccine Technologies Products and Services
11.2.4 Pfizer Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.2.5 Pfizer Vaccine Technologies SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Vaccine Technologies Products and Services
11.3.4 Bayer Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.3.5 Bayer Vaccine Technologies SWOT Analysis
11.3.6 Bayer Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Vaccine Technologies Products and Services
11.4.4 GE Healthcare Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.4.5 GE Healthcare Vaccine Technologies SWOT Analysis
11.4.6 GE Healthcare Recent Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Vaccine Technologies Products and Services
11.5.4 Glaxosmithkline Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.5.5 Glaxosmithkline Vaccine Technologies SWOT Analysis
11.5.6 Glaxosmithkline Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Vaccine Technologies Products and Services
11.6.4 Johnson and Johnson Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.6.5 Johnson and Johnson Vaccine Technologies SWOT Analysis
11.6.6 Johnson and Johnson Recent Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Vaccine Technologies Products and Services
11.7.4 Thermo Fisher Scientific Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022)
11.7.5 Thermo Fisher Scientific Vaccine Technologies SWOT Analysis
11.7.6 Thermo Fisher Scientific Recent Developments
12 Vaccine Technologies Market Dynamics
12.1 Vaccine Technologies Market Trends
12.2 Vaccine Technologies Market Drivers
12.3 Vaccine Technologies Market Challenges
12.4 Vaccine Technologies Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Vaccine Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Infection
Table 3. Key Players of Allergy
Table 4. Key Players of Cancer
Table 5. Global Vaccine Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Vaccine Technologies Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Vaccine Technologies Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Vaccine Technologies Revenue Market Share by Region (2017-2022)
Table 9. Global Vaccine Technologies Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Vaccine Technologies Market Share by Players (2017-2022)
Table 11. Global Top Vaccine Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Technologies as of 2021)
Table 12. Ranking of Global Top Vaccine Technologies Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Vaccine Technologies Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Vaccine Technologies Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Vaccine Technologies Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Vaccine Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Vaccine Technologies Revenue Market Share by Type (2017-2022)
Table 20. Global Vaccine Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Vaccine Technologies Revenue Market Share by Type (2023-2028)
Table 22. Global Vaccine Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Vaccine Technologies Revenue Market Share by Application (2017-2022)
Table 24. Global Vaccine Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Vaccine Technologies Revenue Market Share by Application (2023-2028)
Table 26. North America Vaccine Technologies Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Vaccine Technologies Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Vaccine Technologies Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Vaccine Technologies Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Vaccine Technologies Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Vaccine Technologies Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Vaccine Technologies Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Vaccine Technologies Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Vaccine Technologies Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Vaccine Technologies Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Vaccine Technologies Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Vaccine Technologies Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Vaccine Technologies Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Vaccine Technologies Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Vaccine Technologies Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Vaccine Technologies Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Vaccine Technologies Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Vaccine Technologies Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Vaccine Technologies Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Vaccine Technologies Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Vaccine Technologies Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Vaccine Technologies Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Vaccine Technologies Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Vaccine Technologies Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Vaccine Technologies Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Vaccine Technologies Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Vaccine Technologies Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Vaccine Technologies Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Vaccine Technologies Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Vaccine Technologies Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Vaccine Technologies Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Vaccine Technologies Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Vaccine Technologies Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Vaccine Technologies Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Vaccine Technologies Revenue by Country (2023-2028) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Vaccine Technologies Product and Services
Table 64. Abbott Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 65. Abbott Vaccine Technologies SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Vaccine Technologies Product and Services
Table 70. Pfizer Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 71. Pfizer Vaccine Technologies SWOT Analysis
Table 72. Pfizer Recent Developments
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Vaccine Technologies Product and Services
Table 76. Bayer Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 77. Bayer Vaccine Technologies SWOT Analysis
Table 78. Bayer Recent Developments
Table 79. GE Healthcare Company Details
Table 80. GE Healthcare Business Overview
Table 81. GE Healthcare Vaccine Technologies Product and Services
Table 82. GE Healthcare Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 83. GE Healthcare Vaccine Technologies SWOT Analysis
Table 84. GE Healthcare Recent Developments
Table 85. Glaxosmithkline Company Details
Table 86. Glaxosmithkline Business Overview
Table 87. Glaxosmithkline Vaccine Technologies Product and Services
Table 88. Glaxosmithkline Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 89. Glaxosmithkline Vaccine Technologies SWOT Analysis
Table 90. Glaxosmithkline Recent Developments
Table 91. Johnson and Johnson Company Details
Table 92. Johnson and Johnson Business Overview
Table 93. Johnson and Johnson Vaccine Technologies Product and Services
Table 94. Johnson and Johnson Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 95. Johnson and Johnson Vaccine Technologies SWOT Analysis
Table 96. Johnson and Johnson Recent Developments
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Vaccine Technologies Product and Services
Table 100. Thermo Fisher Scientific Vaccine Technologies Revenue in Vaccine Technologies Business (2017-2022) & (US$ Million)
Table 101. Thermo Fisher Scientific Vaccine Technologies SWOT Analysis
Table 102. Thermo Fisher Scientific Recent Developments
Table 103. Vaccine Technologies Market Trends
Table 104. Vaccine Technologies Market Drivers
Table 105. Vaccine Technologies Market Challenges
Table 106. Vaccine Technologies Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Vaccine Technologies Sales Market Share by Type: 2021 VS 2028
Figure 2. Infection Features
Figure 3. Allergy Features
Figure 4. Cancer Features
Figure 5. Global Vaccine Technologies Sales Market Share by Application: 2021 VS 2028
Figure 6. Humans Case Studies
Figure 7. Animals Case Studies
Figure 8. Vaccine Technologies Report Years Considered
Figure 9. Global Vaccine Technologies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Vaccine Technologies Market Size 2017-2028 (US$ Million)
Figure 11. Global Vaccine Technologies Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Vaccine Technologies Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Vaccine Technologies Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Vaccine Technologies Market Share by Players in 2021
Figure 15. Global Top Vaccine Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Technologies as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Vaccine Technologies Revenue in 2021
Figure 17. North America Vaccine Technologies Revenue Market Share by Company in 2021
Figure 18. North America Vaccine Technologies Revenue Market Share by Type (2017-2028)
Figure 19. North America Vaccine Technologies Revenue Market Share by Application (2017-2028)
Figure 20. North America Vaccine Technologies Revenue Share by Country (2017-2028)
Figure 21. U.S. Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Vaccine Technologies Revenue Market Share by Company in 2021
Figure 24. Europe Vaccine Technologies Revenue Market Share by Type (2017-2028)
Figure 25. Europe Vaccine Technologies Revenue Market Share by Application (2017-2028)
Figure 26. Europe Vaccine Technologies Revenue Share by Country (2017-2028)
Figure 27. Germany Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 28. France Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Vaccine Technologies Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Vaccine Technologies Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Vaccine Technologies Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Vaccine Technologies Revenue Share by Region (2017-2028)
Figure 36. China Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 39. India Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Vaccine Technologies Revenue Market Share by Company in 2021
Figure 48. Latin America Vaccine Technologies Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Vaccine Technologies Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Vaccine Technologies Revenue Share by Country (2017-2028)
Figure 51. Mexico Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Vaccine Technologies Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Vaccine Technologies Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Vaccine Technologies Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Vaccine Technologies Revenue Share by Country (2017-2028)
Figure 58. Turkey Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 60. U.A.E Vaccine Technologies Revenue (2017-2028) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 62. Pfizer Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 63. Bayer Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 64. GE Healthcare Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 65. Glaxosmithkline Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 66. Johnson and Johnson Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Vaccine Technologies Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed